Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines

Pancreatic ductal adenocarcinoma (PDAC) correlates with high mortality and is about to become one of the major reasons for cancer-related mortality in the next decades. One reason for that high mortality is the limited availability of effective chemotherapy as well as the intrinsic or acquired resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Lukas M., Lagies, Simon, Guenzle, Jessica, Fichtner-Feigl, Stefan, Wittel, Uwe A., Kammerer, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290296/
https://www.ncbi.nlm.nih.gov/pubmed/32438599
http://dx.doi.org/10.3390/cells9051251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290296/
https://www.ncbi.nlm.nih.gov/pubmed/32438599
http://dx.doi.org/10.3390/cells9051251

Ejemplares similares